Crossmark

Novel GLP-1 (Glucagon-Like Peptide-1) Analogues and Insulin in the Treatment for Alzheimer’s Disease and Other Neurodegenerative Diseases

Crossref DOI link: https://doi.org/10.1007/s40263-015-0301-8

Published Online: 2015-12-14

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Calsolaro, Valeria

Edison, Paul
Funding

Funding for this research was provided by:

Alzheimer's Drug Discovery Foundation (US)

Alzheimer’s Research UK (GB)

Alzheimer's Society (GB)

Van Geest Foundation

Medical Research council, UK

Novo Nordisk (DK)

GE Healthcare (GB)

Piramal Life Science
License Information

Text and Data Mining valid from 2015-12-01